Koutsilieris, M <br/><br/>
Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer.  [electronic resource] 

 -  Molecular medicine (Cambridge, Mass.)  Apr 2000 
 - 251-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1076-1551 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Cell Division--drug effects<br/>Cell Survival--drug effects<br/>Drug Resistance, Neoplasm<br/>Hormones--pharmacology<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Neoplasm Metastasis--pathology<br/>Osteoblasts--drug effects<br/>Prostatic Neoplasms--drug therapy<br/>Urokinase-Type Plasminogen Activator--metabolism